Nextage Therapeutics Ltd

ILA 33.30As of Sun 8 Nov 2026, 12:00 UTC
TASE:NXTGHealthcare
Country Israel
PE (Fwd) •••
TSR 6Y CAGR (33.99%)
Div yield —
ROE (73.42%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.11
PE TTM —
TSR TTM —
Mkt cap ILS 26.99M
ROIC (24.11%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 32
(4.85%)
81.11%
Sell 1|6|2|2|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareILS
0.68
0.69
0.72
0.80
8.38%
1.75%
9.49%
27.45%
RevenueILS M
2.033
2.047
2.152
2.185
0.07%
3.10%
11.61%
13.34%
Peers (US$8.434M)
Cap (US$)
PE
8.604M
—
Capital
TTM
5Y
10Y
Leveragex
1.117
0.087
0.057
EBIT/Intx
4.573
0.305
0.277
Own earn%
(32.07)
(29.66)
(20.47)
Sh yield%
51.13
41.83
40.81
Owners
Insiders/Inst%
4.02
76.47
Short interest%
1.16
SBC / revenue%
4.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
25–28
$1 testx
—
Incr. ROIC%
9